Novo Nordisk A/S News - June 2026
Novo Nordisk Wegovy enters Medicare pilot, slashing monthly costs to $50
Medicare launched a temporary 18-month pilot program to cover GLP-1 weight-loss drugs for the first time. The initiative provides millions of seniors and...
Novo Nordisk Rallies 5%, Foundation Launches $69 Million Obesity Research Hub
The Novo Nordisk Foundation launched the CardioMetabolic Bridge on Friday to commercialize academic research in obesity and type 2 diabetes. This pan-European...
Novo Nordisk Rejects $25 Million Ransom, Hackers Leak 1.3TB Data
Cyber-extortion group FulcrumSec claimed responsibility for a major data breach at Novo Nordisk involving 1.3 terabytes of stolen information. The group began...
Novo Nordisk Wins UK Approval for Wegovy Pill, First Weight-Loss Tablet
Novo Nordisk received approval from the U.K. Medicines and Healthcare products Regulatory Agency for its daily Wegovy weight-loss pill. This marks the first...